The 14th World Congress of Cardiology, held in Sydney 5–9 May 2002 (the first time ever in the antipodes), was a joint meeting with the 50th anniversary meeting of the Cardiac Society of Australia and New Zealand (CSANZ). The Congress is the principal meeting of the World Heart Federation, a body comprising all of the world's cardiac societies and heart foundations. Delegates came from 115 countries, and there was a total registration of just over 9000. More than 3000 abstracts were received from investigators in 82 countries.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- Department of Cardiology, Concord Repatriation General Hospital, Concord, NSW.
Correspondence: ben@gmp.usyd.edu.au
- 1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
- 2. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
- 3. Duc, Cazabat, Lejoyeux M, et al. Severe depression is frequent but still untreated in patients with congestive heart failure. J Am Coll Cardiol 2002; 39(9) Suppl B: 424B.
- 4. Post F, Peetz D, Knoess P, et al. Brain natriuretic peptide for the evaluation of dyspneic patients in the emergency room. J Am Coll Cardiol 2002; 39(9) Suppl B: 193B.
- 5. Aronson D, Horton DP, Burger AJ. Neseritide improves heart rate variability in patients with decompensated heart failure. J Am Coll Cardiol 2002; 39(9) Suppl B: 403B.
- 6. Allada CS, Keogh AM, Kotlyer E, et al. Carvedilol in elderly heart failure patients. J Am Coll Cardiol 2002; 39(9) Suppl B: 407B.
- 7. Krum H, Coats AJS, Fowler MB, et al. The COPERNICUS Study Group. Effect of carvedilol on clinical status early following initiation of therapy in patients with severe chronic heart failure: results of the COPERNICUS Study. J Am Coll Cardiol 2002; 39(9) Suppl B: 404B.
- 8. Abraham WT, Fisher W, Smith A, et al. Long term improvement in functional status, quality of life and exercise capacity in cardiac resynchronization therapy: the MIRACLE Trial experience. J Am Coll Cardiol 2002; 39(9) Suppl B: 465B.
- 9. Atienza F, Ojeda S, Osca J, et al. Impact of an interactive education and home-monitoring program on hospital readmissions, survival and quality of life among patients with congestive heart failure. The PRICE Multicentre Study. J Am Coll Cardiol 2002; 39(9) Suppl B: 448B.
- 10. Stewart S, Horowitz JD. Reduced morbidity, prolonged survival and lower health care costs: the long-term effects of post discharge, home-based intervention in chronic heart failure. J Am Coll Cardiol 2002; 39(9) Suppl B: 449B.
- 11. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001; 357: 279-280.
- 12. Smits PC, Maat L, Bolraap J, et al. Initial experience of percutaneous transendocardial delivery of autologous skeletal myoblasts for cellular myoplasty: a safety feasibility study. J Am Coll Cardiol 2002; 39(9) Suppl B; 191B.
Online responses are no longer available. Please refer to our instructions for authors page for more information.